Helicobacter Infection

The FDA has approved two treatments for Helicobacter pylori infection in adults. Both regimens contain vonoprazan, a potassium-competitive acid blocker. The announcement was the top story in gastroenterology last week.

In this video exclusive, William D. Chey, MD, from the University of Michigan, discussed results from a pivotal phase 3 trial of vonoprazan in Helicobacter pylori infection.

The FDA approved Talicia for the treatment of Helicobacter pylori infection in adults, manufacturer Redhill Biopharma announced.